SCHEMBL30400780

SCHEMBL30400780

CN1CCC(n2cc(NC(=O)c3cnc4[nH]cc(-c5ccc6nccnc6c5)c4c3)cn2)CC1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MAPK7 Q13164 1/20 0.49
▸ DYRK1A Q13627 12/20 0.48
▸ CLK2 P49760 5/20 0.48
▸ CLK3 P49761 5/20 0.48
▸ GSK3B P49841 6/20 0.48
▸ OGA O60502 1/20 0.47
▸ CLK1 P49759 3/20 0.47
▸ DYRK1B Q9Y463 3/20 0.47
▸ MELK Q14680 2/20 0.47
▸ FLT3 P36888 1/20 0.46
▸ DYRK2 Q92630 1/20 0.44
▸ ROCK2 O75116 1/20 0.43
▸ ROCK1 Q13464 1/20 0.43
▸ PAK1 Q13153 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26175149 1.00 MAPK7 (0.49) MAPK7DYRK1ACLK2CLK3GSK3B
SCHEMBL26175148 0.91 FLT3 (0.48) MAPK7DYRK1ACLK2CLK3GSK3B
SCHEMBL30398955 0.91 FLT3 (0.48) MAPK7DYRK1ACLK2CLK3GSK3B
SCHEMBL26175109 0.90 DYRK1A (0.48) MAPK7DYRK1AGSK3BOGACLK1
SCHEMBL30399658 0.90 DYRK1A (0.48) MAPK7DYRK1AGSK3BOGACLK1
SCHEMBL26175115 0.88 DYRK1A (0.48) MAPK7DYRK1ACLK2CLK3GSK3B
SCHEMBL30400698 0.88 DYRK1A (0.48) MAPK7DYRK1ACLK2CLK3GSK3B
SCHEMBL30398632 0.88 DYRK1A (0.48) MAPK7DYRK1ACLK2CLK3GSK3B
SCHEMBL30400661 0.88 DYRK1A (0.48) MAPK7DYRK1ACLK2CLK3GSK3B
SCHEMBL26175150 0.88 DYRK1A (0.48) MAPK7DYRK1ACLK2CLK3GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415817-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 — — EP claimed
WO-2023064349-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 — — WO claimed
Send feedback